Literature DB >> 2507296

Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation.

L Stefaneanu1, K Kovacs, E Horvath, S L Asa, N E Losinski, N Billestrup, J Price, W Vale.   

Abstract

The effect of protracted GH-releasing factor (GRF) stimulation on adenohypophysial morphology was investigated in six mice transgenic for human GRF (hGRF). All animals had significantly higher plasma levels of GH and GRF and greater body weights than controls. Eight-month-old mice were killed, and the markedly enlarged pituitaries were studied by histology, immunocytochemistry, electron microscopy, and immunogold method, using double labeling at ultrastructural level. In all pituitaries, a massive hyperplasia, chiefly of mammosomatotrophs, was found. These bihormonal cells, containing GH and PRL, were demonstrated by light microscopy and ultrastructural immunocytochemistry. Electron microscopy revealed the presence of cells with characteristics of GH cells in three pituitaries and cells resembling human adenomatous mammosomatotrophs in the other three glands. All of these cells, regardless of their ultrastructural features, contained secretory granules heavily labeled for GH by immunogold technique; PRL labeling varied from cell to cell, with the predominance of a weak immunostaining and was colocalized with GH in secretory granules. These results indicate that chronic exposure to GRF excess leads to mammosomatotroph hyperplasia. It is suggested that GH cells proliferate and transform to mammosomatotrophs in response to GRF stimulation. Focal PRL cell hyperplasia noted in three pituitaries could also be due to a GRF effect. Longer exposure to GRF is needed to clarify whether GRF can cause adenoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507296     DOI: 10.1210/endo-125-5-2710

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice.

Authors:  S L Asa; K T Coschigano; L Bellush; J J Kopchick; S Ezzat
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Effects of overexpression of growth hormone-releasing hormone on the hypothalamo-pituitary-gonadal function in the mouse.

Authors:  L Debeljuk; R W Steger; J C Wright; J Mattison; A Bartke
Journal:  Endocrine       Date:  1999-10       Impact factor: 3.633

Review 3.  Molecular biology of the regulation of hypothalamic hormones.

Authors:  J M Rondeel; I M Jackson
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

4.  Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.

Authors:  K Thapar; K Kovacs; L Stefaneanu; B Scheithauer; D W Killinger; R V Lioyd; H S Smyth; A Barr; M O Thorner; B Gaylinn; E R Laws
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

Review 5.  Molecular basis of pituitary oncogenesis.

Authors:  M Tada; H Kobayashi; T Moriuchi
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

6.  Hereditary pituitary hyperplasia with infantile gigantism.

Authors:  Sven Gläsker; Alexander O Vortmeyer; Antony R A Lafferty; Paul L Hofman; Jie Li; Robert J Weil; Zhengping Zhuang; Edward H Oldfield
Journal:  J Clin Endocrinol Metab       Date:  2011-10-05       Impact factor: 5.958

7.  Idiopathic prolactin cell hyperplasia of the pituitary mimicking prolactin cell adenoma: a morphological study including immunocytochemistry, electron microscopy, and in situ hybridization.

Authors:  V Jay; K Kovacs; E Horvath; R V Lloyd; H S Smyth
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.

Authors:  Raul M Luque; Beatriz S Soares; Xiao-ding Peng; Sonia Krishnan; Jose Cordoba-Chacon; Lawrence A Frohman; Rhonda D Kineman
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

9.  The Pituitary in Gigantism.

Authors:  Bernd W. Scheithauer; Kalman T. Kovacs; Lucia Stefaneanu; Eva Horvath; Laurie A. Kane; William F. Young; Ricardo V. Lloyd; Raymond V. Randall; Dudley H. Davis
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

10.  Mitotic Counts in Rat Adenohypophysial Thyrotrophs and Somatotrophs: Effects of Short-Term Thyroidectomy, Thyroxine, and Thyrotropin-Releasing Hormone.

Authors:  Andrés Quintanar-Stephano; Carlos Valverde-R; Kalman Kovacs
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.